Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keryx Biopharmaceuticals IncfiledCriticalKeryx Biopharmaceuticals Inc
Priority claimed from PCT/US2010/042788external-prioritypatent/WO2011011541A1/en
Publication of UA107803C2publicationCriticalpatent/UA107803C2/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Винахід стосується залізоцитратної пігулки, що містить 65-92 мас. % цитрату заліза(III), способу отримання та застосування для профілактики або лікування гіперфосфатемії.The invention relates to an iron citrate tablet containing 65-92 wt. % citrate of iron (III), a method of production and use for the prevention or treatment of hyperphosphatemia.
UAA201202006A2009-07-212010-07-21DOSAGE FORM OF IRON CITRATE (iii)
UA107803C2
(en)
Pharmaceutical composition for use in the treatment or prevention of vitamin and mineral deficiencies in patients which have been subjected to gastric bypass-surgery.